Millennium Management LLC decreased its position in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 87.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 16,830 shares of the insurance provider's stock after selling 116,033 shares during the period. Millennium Management LLC owned about 0.09% of AMERISAFE worth $867,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AMSF. Franklin Resources Inc. purchased a new stake in shares of AMERISAFE in the fourth quarter worth approximately $359,000. Ameriprise Financial Inc. lifted its position in AMERISAFE by 7.8% in the 4th quarter. Ameriprise Financial Inc. now owns 102,843 shares of the insurance provider's stock worth $5,301,000 after buying an additional 7,399 shares in the last quarter. Deutsche Bank AG boosted its stake in shares of AMERISAFE by 52.0% during the 4th quarter. Deutsche Bank AG now owns 18,610 shares of the insurance provider's stock valued at $959,000 after buying an additional 6,366 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of AMERISAFE by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 661,795 shares of the insurance provider's stock valued at $34,109,000 after acquiring an additional 21,799 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of AMERISAFE in the fourth quarter worth $9,708,000. 97.41% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, JMP Securities reaffirmed a "market outperform" rating and set a $65.00 price objective on shares of AMERISAFE in a research report on Wednesday, April 30th.
Read Our Latest Report on AMSF
AMERISAFE Stock Down 0.7%
Shares of NASDAQ:AMSF traded down $0.30 on Tuesday, reaching $45.35. The company had a trading volume of 116,764 shares, compared to its average volume of 108,121. The stock has a market capitalization of $863.92 million, a P/E ratio of 14.17 and a beta of 0.42. The stock has a 50-day moving average price of $47.86 and a 200 day moving average price of $50.48. AMERISAFE, Inc. has a twelve month low of $41.97 and a twelve month high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The insurance provider reported $0.60 EPS for the quarter, beating the consensus estimate of $0.59 by $0.01. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. The company had revenue of $83.78 million for the quarter, compared to the consensus estimate of $76.66 million. On average, sell-side analysts predict that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.
AMERISAFE Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 13th will be paid a dividend of $0.39 per share. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.56 annualized dividend and a yield of 3.44%. AMERISAFE's dividend payout ratio is 62.90%.
About AMERISAFE
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Featured Articles

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.